STAG1 and urinary bladder carcinoma: We transplanted STAG2 mutated (p.K983*) UM-UC-3 bladder cancer cells, which were transduced with in vitro validated shRNAs targeting STAG1, into immunocompromised mice to evaluate the effects of partial STAG1 suppression in vivo (Fig S2A–D).